ICT-01(Imcheck Therapeutics) | Interleukin Related interleukin-related.com

Product Name :
ICT-01(Imcheck Therapeutics)

Search keywords :
BTN3A1

drugId :
null

Target Vo:
Butyrophilin subfamily 3 member A1

Target Vo Short Name :
CD277

Moa_Name:
Anti-Butyrophilin subfamily 3 member A1

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
ImCheck Therapeutics SAS

Active Company_Name :
ImCheck Therapeutics SAS

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Goat Anti-Rabbit IgG Antibody Cancer
Anti-Mouse IL-1R Antibody (JAMA-147) Interleukin Related
C3 Antibody: C3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 187 kDa, targeting to C3. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts